Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China

Clinical trial NCT02955316 · COMPLETED

Trial details

NCT number: NCT02955316
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Irritable Bowel Syndrome (IBS)

Start date: 2017-02-10
Primary completion: 2017-09-30
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.